Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998
Standard
Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998. / Winzer, Klaus-Jürgen; Buchholz, Anika; Guski, Hans; Frohberg, Hans-Dieter; Diekmann, Felix; Possinger, Kurt; Sauerbrei, Willi.
in: ONKOLOGIE, Jahrgang 36, Nr. 12, 2013, S. 727-36.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998
AU - Winzer, Klaus-Jürgen
AU - Buchholz, Anika
AU - Guski, Hans
AU - Frohberg, Hans-Dieter
AU - Diekmann, Felix
AU - Possinger, Kurt
AU - Sauerbrei, Willi
N1 - © 2013 S. Karger GmbH, Freiburg.
PY - 2013
Y1 - 2013
N2 - BACKGROUND: We have analyzed the patient population of one clinic (Charité) over a period of 15 years. Besides the changes in the technical facilities and therapeutical guidelines during these years, this period also reflects the changes in the health system attributable to the reunification of East and West Germany. Until now only few analyses for breast cancer patients from the German speaking area have been reported.PATIENTS AND METHODS: All 2,062 patients undergoing surgical treatment for breast cancer between 1984 and 1998 were documented and followed up until 2007. The analysis included 1,560 patients with a primary breast cancer who fulfilled certain inclusion criteria. The treatment strategies applied to this population are presented in 3 time periods (1984-1990, 1991-1993, and 1994-1998). The effects of prognostic factors on overall survival were investigated using univariate analyses.RESULTS: The percentage of pT1 tumors changed from 50.7% in the first period to 63.1% in the third period. The percentage of node-negative patients hardly changed with time (on average 61.6%). However, the percentage of patients with less than 10 assessed nodes decreased from 48.4% to 6.7% and 2.5% for the 3 periods, respectively. Therapeutic strategies changed drastically. Survival rate increased substantially, most likely due to improved therapeutic strategies, but also for other reasons not considered in the analysis.
AB - BACKGROUND: We have analyzed the patient population of one clinic (Charité) over a period of 15 years. Besides the changes in the technical facilities and therapeutical guidelines during these years, this period also reflects the changes in the health system attributable to the reunification of East and West Germany. Until now only few analyses for breast cancer patients from the German speaking area have been reported.PATIENTS AND METHODS: All 2,062 patients undergoing surgical treatment for breast cancer between 1984 and 1998 were documented and followed up until 2007. The analysis included 1,560 patients with a primary breast cancer who fulfilled certain inclusion criteria. The treatment strategies applied to this population are presented in 3 time periods (1984-1990, 1991-1993, and 1994-1998). The effects of prognostic factors on overall survival were investigated using univariate analyses.RESULTS: The percentage of pT1 tumors changed from 50.7% in the first period to 63.1% in the third period. The percentage of node-negative patients hardly changed with time (on average 61.6%). However, the percentage of patients with less than 10 assessed nodes decreased from 48.4% to 6.7% and 2.5% for the 3 periods, respectively. Therapeutic strategies changed drastically. Survival rate increased substantially, most likely due to improved therapeutic strategies, but also for other reasons not considered in the analysis.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Breast Neoplasms
KW - Cancer Care Facilities
KW - Female
KW - Germany
KW - History, 20th Century
KW - Humans
KW - Longitudinal Studies
KW - Mastectomy
KW - Middle Aged
KW - Prevalence
KW - Risk Factors
KW - Survival Rate
KW - Treatment Outcome
U2 - 10.1159/000356805
DO - 10.1159/000356805
M3 - SCORING: Journal article
C2 - 24356564
VL - 36
SP - 727
EP - 736
JO - ONKOLOGIE
JF - ONKOLOGIE
SN - 0378-584X
IS - 12
ER -